SPIR vs UTHR · rev $110.5M vs P/E 20, rev $2.88B
Spire Global Inc (SPIR) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Spire Global Inc (SPIR) is a specialty business services company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported SPIR revenue for 2024-12-31 was $110.5M. Net income was -$102.8M. Revenue was up 13.2% from 2023-12-31 to 2024-12-31. SPIR currently screens at market cap $351.2M.
Latest reported UTHR revenue for 2024-12-31 was $2.88B. Net income was $1.20B. Revenue was up 23.6% from 2023-12-31 to 2024-12-31. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
SPIR currently screens at market cap $351.2M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the SPIR and UTHR stock pages for the full models.
Not investment advice.